Literature DB >> 31497785

The safety of using active triage to provide advice rather than a face-to-face neurology outpatient appointment.

Karina Bennett1, Louis de Boisanger2, Fiona Moreton2, Richard Davenport2, Jon Stone2.   

Abstract

BACKGROUND: Neurology referrals from primary care are increasing. Actively triaging referrals is one way of providing a better patient-focussed service.
METHODS: We reviewed the safety and cost-effectiveness of 'advice only' rather than face-to-face appointments for neurology patients via active triage. Referrals triaged as 'advice only' were identified over a 6-month period. Data were collected on reason for referral, opinion of triaging neurologist and whether the patient re-presented to neurology within 12 months.
RESULTS: A total of 10% (236 out of 2,445) of referred patients were given advice only after active triage. A total of 71% (n = 167) had no further secondary care presentations in 12 months. The most common presentation was headache (n = 57; 13%). One patient had a major diagnostic change following delayed review.
CONCLUSIONS: 'Advice only' allows patients to receive timely advice and management. It appears safe and is likely to be cost effective, although further data are required on whether it provides satisfactory outcomes for patients and general practitioners.

Entities:  

Keywords:  active triage; misdiagnosis; neurology; outpatients; safety

Mesh:

Year:  2019        PMID: 31497785     DOI: 10.4997/JRCPE.2019.305

Source DB:  PubMed          Journal:  J R Coll Physicians Edinb        ISSN: 1478-2715


  2 in total

1.  Delivering an advice and guidance service in neurology.

Authors:  Kirstie N Anderson; Naomi Warren; Martin Duddy; Paul McKean; James A L Miller
Journal:  Pract Neurol       Date:  2022-01-24

2.  A service evaluation of e-triage in the osteoporosis outpatient clinic-an effective tool to improve patient access?

Authors:  John R Lindsay; G Lawrenson; S English
Journal:  Arch Osteoporos       Date:  2020-03-21       Impact factor: 2.617

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.